Rogers' regional medical director to address issue of childhood anxiety at NATSAP conference

NewsGuard 100/100 Score

Stephanie C. Eken, M.D., F.A.A.P., a regional medical director with Rogers Behavioral Health System, will address the issue of childhood anxiety at the 2015 National Association of Therapeutic Schools and Programs (NATSAP) conference on February 6 in Nashville, TN. Dr. Eken will co-present a workshop session "Therapeutic Approaches to Reduce Family Accommodation in Adolescents with Anxiety Disorders" with Eddie Tomaich, manager of the Child Center at Rogers Memorial Hospital.

NATSAP's annual conference brings together hundreds of mental health and allied professionals who work with children, adolescents and their families. Members include therapeutic schools, residential treatment programs, wilderness programs, outdoor therapeutic programs, young adult programs and home-based residential programs.

Rogers Behavioral Health–Nashville scheduled to open May 2015

Dr. Eken serves as the regional medical director for Rogers Behavioral Health–Nashville, which is scheduled to open in May 2015. The Nashville location will offer two levels of OCD and anxiety treatment: an intensive outpatient program (IOP), which consists of treatment three hours a day, four days per week; and a partial hospitalization program (PHP), which consists of treatment six hours a day, four days per week. At both levels of care, treatment often lasts four to six weeks.

"I am excited to have this opportunity to bring Rogers' high quality care to the children, teens and adults in the Nashville area," says Dr. Eken. With separate programming for adults and for children and adolescents, the Nashville location will utilize evidence-based treatment such as cognitive behavioral therapy along with exposure and response prevention. Dr. Eken will be joined by board-certified psychiatrists, psychologists and therapists in these intensive, specialized treatment services.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Is psilocybin safe for treating depression and anxiety?